Medical treatment of Parkinson's disease

被引：26

作者：

Fahn, S ^{[1
]}

机构：

[1] Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA

来源：

JOURNAL OF NEUROLOGY | 1998年 / 245卷 / Suppl 3期

关键词：

D O I：

10.1007/PL00007742

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：P15 / P24

页数：10

共 21 条

[11] EARLY DEVELOPMENT OF LEVODOPA-INDUCED DYSKINESIAS AND RESPONSE FLUCTUATIONS IN YOUNG-ONSET PARKINSONS-DISEASE [J].

KOSTIC, V ;

PRZEDBORSKI, S ;

FLASTER, E ;

STERNIC, N .

NEUROLOGY, 1991, 41 (02) :202-205

[12] Dopamine- and L-beta-3,4-dihydroxyphenylalanine hydrochloride (L-DOPA)-induced cytotoxicity towards catecholaminergic neuroblastoma SH-SY5Y cells - Effects of oxidative stress and antioxidative factors [J].

Lai, CT ;

Yu, PH .

BIOCHEMICAL PHARMACOLOGY, 1997, 53 (03) :363-372

[13] ASCORBIC-ACID PROTECTS AGAINST LEVODOPA-INDUCED NEUROTOXICITY ON A CATECHOLAMINE-RICH HUMAN NEUROBLASTOMA CELL-LINE [J].

PARDO, B ;

MENA, MA ;

FAHN, S ;

DEYEBENES, JG .

MOVEMENT DISORDERS, 1993, 8 (03) :278-284

[14]

Quinn N, 1987, Mov Disord, V2, P73, DOI 10.1002/mds.870020201

[15] A CASE AGAINST EARLY LEVODOPA TREATMENT OF PARKINSONS-DISEASE [J].

QUINN, NP .

CLINICAL NEUROPHARMACOLOGY, 1994, 17 :S43-S49

[16]

Rajput A, 1997, BIOMOLECULES, V24, pS23

[17]

SHOULSON I, 1989, NEW ENGL J MED, V321, P1364

[18]

SHOULSON I, 1993, NEW ENGL J MED, V328, P176, DOI 10.1056/NEJM199301213280305

[19]

SHOULSON I, 1995, ARCH NEUROL-CHICAGO, V52, P237

[20]

Wagner ML, 1996, ANN CLIN LAB SCI, V26, P389

← 1 2 3 →